The systemic and/or local effects of the hydrocephalic brain were investigated in DOCA-NaCl-hypertensive Dahl R rats induced by 250 mg kg À1 DOCA in silicone and 1% saline water. After a 1-week recovery with 0.3% NaCl chow and tap water, one group had the aqueduct of Sylvius blocked with silicone and epoxy materials with a control sham group matching mean blood pressure (BP) and body weight. The 4-week-postsurgery BP on the 0.3% NaCl diet averaged 161±3.2 in the sham group and 146 ± 2.3 mm Hg in the blocked group (Po0.0001). Both groups were then given an 8% NaCl diet and after 4 weeks, the sham group's BP was increased further with markedly increased mortality: 186 mm Hg vs. 154 mm Hg (Po0.0001); 12 sham rats died after 11 weeks, while all the blocked rats survived (Po0.0001). A transient change in plasma Na levels was observed in the blocked group after 48 h on the 8% NaCl diet. At 14 weeks, 0 sham rats survived, compared with 10 out of 16 blocked rats (Po0.0001). After 11 weeks on 8% NaCl, the average tail venous pressure in the sham group was significantly higher than that of the blocked rats (Po0.0001) indicating the end stage of renal and heart failure. The hearts and kidneys weighed significantly more in the sham vs. the blocked rats (Po0.0001 for both groups). These results indicate that the aqueduct block prevents post-DOCA hypertension and cardio-renal injuries, suggesting that centralized third ventricular brain signaling has a role in salt-genetic hypertension.
INTRODUCTION
There is sufficient evidence that the anteroventral third ventricle (AV3V) area of the brain is a major location of Na-sensitive receptors and is involved in NaCl hypertension. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] The AV3V is vital for maintaining normal body homeostasis and cardiovascular responses. We need to understand how NaCl works in raising blood pressure (BP) and the role of the brain's NaCl-control center. Other studies and our results have shown that the AV3V region is a major location of sodium-sensitive receptors and is involved in NaCl-sensitive hypertension. [1] [2] [3] [4] [5] [6] [7] [8] [9] This finding indicates that not only the intact AV3V, but also the intact cerebroventricular volume space, is required for the NaCl-control center to correctly perceive the NaCl signal. Central nervous system involvement in the pathogenesis of salt-genetic hypertension is indicated in many other studies. [14] [15] [16] Induced hydrocephalus or AV3V lesion prevents deoxycorticosterone acetate (DOCA)-NaCl hypertension, creating a model of renin-suppressed, volume-expanded hypertension. 5, 13 If DOCA-NaCl hypertension requires changes in body fluid volumes or sodium balance, the protective effect of the AV3V lesion may result from a disturbance in the necessary changes in fluid or the electrolyte balance. This outcome may result from the influence of a central mechanism of vasopressin (VP) action, which may alter the protection or release of a natriuretic factor. VP may act centrally or on neural target areas, such as paraventricular nuclei (PVN) and supraoptic nuclei, which are involved in cardiovascular regulation. 14, 15 The PVN project sympathetic neurons in the brainstem and spinal cord, and the vagus nuclei regulate the cardiovascular system. 14, 15 Thus, the AV3V region, a major location of the NaCl receptor center that is involved in Na-dependent hypertension, may be interfering with the VP's neurogenic vasoconstriction activity in DOCA-NaCl hypertension.
In our previous study, we examined mostly BP and mortality in hydrocephalic Dahl S and DOCA-hypertensive Dahl R rats. [1] [2] [3] In the present study, we used post-DOCA Dahl R rats with an 8% high NaCl diet to examine the systemic and local effects of induced hydrocephalus on physiological responses. In addition to effects on BP and mortality, we examined acute physiological responses to the 8% NaCl diet, including water intake and output, plasma Na levels and Na excretions, and the long-term effects of venous pressures and cardio-renal responses. regular diet and tap water for 1 week to readjust in this new environment before starting the actual experiment.
DOCA-NaCl treatment
DOCA-NaCl hypertension was induced in 4-week-old uninephrectomized male Dahl R rats by subcutaneous 250 mg kg À1 DOCA silicone disk implantation, with regular chow and drinking water containing 1% NaCl and 0.2% KCl. The DOCA disk was removed after 4 weeks, and the rats were switched to 0.3% NaCl Purina chow and tap water for a 1-week recovery. The rats were then weighed, and intra-arterial BP was measured under Brevital anesthesia (50 mg kg À1 ). Using body weights (BWs) and BPs, the post-DOCA rats were divided into two groups with similar mean BWs (211 g vs. 219 g) and BPs (146 mm Hg vs. 150 mm Hg).
Aqueductal lesion
The aqueduct of Sylvius was blocked stereotaxically under pentobarbital anesthesia with a local injection of silicone and epoxy materials, using the method described in our previous studies. [1] [2] [3] [4] After a 1-week recovery from the DOCA treatment with 0.3% NaCl chow and tap water, one group had the aqueduct of Sylvius blocked with silicone and epoxy materials, and the other group (with a matching mean BP and BW) had a sham block. The block was confined to the aqueduct. All aqueduct-blocked rats developed a hydrocephalic enlargement of the lateral sides, widening of the slit-like 3V. Sham lesions were performed by making a hole in a region of the skull surface without the cannula entering the brain to ensure that no brain lesions resulted from the cannula itself. The rats were kept on the 0.3% low NaCl diet with tap water for an additional 4 weeks, while they were recovering from the DOCA and saline to allow the brains to develop hydrocephalus. Although the swollen condition is not visible, it is possible that the tissue surrounding the 3V site tends to become slightly edematous during the DOCA-NaCl treatment, causing the ependymal cells and the unmyelinated nerve fibers in the walls of the slit to touch one another when they come into contact with the opposite walls. Widening the slit-like 3V by the blocking aqueduct would prevent the walls to touch and reverse the lingering central nervous system effects of DOCA-NaCl. At the end of the study, the brains were fixed using a 10% neutral formalin solution and dissected to verify the blocked site microscopically, as in our previous study. 1 
Experimental measurements
At the end of the 4-week recovery period, BW, intra-arterial BP and hematocrit were measured, and both groups of rats began an 8% NaCl diet. Blood samples were collected from tail veins after 48 h, and 24-h urine samples were collected starting at 48-h post 8% NaCl diet through 72 h on the 8% NaCl diet to complete the 24-h urine collection. The baseline and transient plasma Na and urine Na values on the high NaCl diet were compared. After 4 weeks of the high NaCl diet, intra-arterial BP was measured under Brevital anesthesia (50 mg kg À1 ), and hematocrit, plasma Na levels and BW were measured. Tail venous pressure was measured under Brevital anesthesia after 11 weeks on the high NaCl diet. All of the surgical procedures were conducted in accordance with the National Institutes of Health guidelines and University of Minnesota animal care regulations. Mortality, wet and dry heart and kidney weights were ascertained. The aqueduct blocks were verified histologically using the methods outlined in our previous study. 1 Pathological examinations were performed for each rat.
Statistics
The results were analyzed using the least-square method and the two-tailed Student's t-test. The data are expressed as mean ± s.e.m. A P-value o0.05 was considered to be significant.
RESULTS
In our present study, aqueduct-blocked Dahl R rats were used to test acute and long-term systemic and local effects in induced hydrocephalus. Figure 1 shows the average arterial BPs at surgery, 4 weeks postsurgery with a 0.3% low NaCl diet and 4 weeks post high NaCl diet. The post-DOCA sham group's average BP was much higher than that of the truly blocked rats, even after 4 weeks on a 0.3% low NaCl diet (161±3.2 mm Hg vs. 146±2.3 mm Hg; Po0.0001). BPs were further increased in the sham group after 4 weeks.
In Table 1 , water and NaCl intake values were taken from 24-h volumes after 2 days on the 8% high NaCl diet, and the urine volumes were measured from 24-h urine collections starting at 48 h on the high NaCl diet. Water intake and urine output interacted significantly in both the sham and truly blocked groups on the 8% NaCl diet, but the interaction was significantly greater in the sham rats. Furthermore, a significant water accumulation was observed in the sham group rats after 2 days on the 8% NaCl diet (22.72 ± 4.95 ml vs. 19.64±4.54 ml; Po0.0001). Figure 2 shows plasma sodium levels in the sham and truly blocked groups on a post-DOCA 8% NaCl diet. Both the hydrocephalic and sham group rats showed a normal range of plasma Na concentrations before the high NaCl diet was introduced (144 mEq l À1 vs. 141 mEq l À1 , P ¼ NS). After 48 h on the 8% NaCl diet, the truly blocked group averaged a markedly lower [Na] level compared with the sham group (134.9 ± 2.4 mEq l À1 vs. 141.1±1.9 mEq l À1 , Po0.05). After 4 weeks on the 8% NaCl diet, the plasma Na level of the truly blocked group rats returned to the normal physiological range and become similar to that of the sham group (141 mEq l À1 vs. 140 mEq l À1 , P ¼ NS). After 48-72 h on the 8% NaCl diet, the transient urinary Na excretion of the truly blocked rats averaged 14% higher than that of the sham group rats, although the difference was not significant (184 mEq l À1 vs. 210 mEq l À1 ; P ¼ NS). Of interest was the transient drop in the plasma Na level of the hydrocephalic rats. The truly blocked rats had markedly decreased albuminuria after 3 days on the 8% NaCl diet (181 mg per 24 h), while the sham rats averaged 496 mg per 24 h (Po0.0001); furthermore, there was a significantly higher albumin/creatinine ratio in the sham vs. truly blocked rats (36 vs. 14, Po0.0001), indicating that Sham group was randomly assigned 17 rats and 16 rats were assigned to the blocked group. BP was measured again after 5 weeks post-DOCA, while the rats were still on a 0.3% low NaCl diet. After 4 weeks on an 8% high NaCl diet, BP was measured again. The mean BPs were significantly attenuated in the blocked group on either the 0.3 or the 8% NaCl diet, Po0.0001.
kidneys that were already injured by DOCA-NaCl hypertension responded immediately when exposed to the high NaCl diet among the sham group rats, but were protected in the truly blocked rats. Venous pressures were measured at the tail veins after 11 weeks on the 8% NaCl diet. The sham group had a much higher average venous pressure than the truly blocked group did (29 ± 5.9 mm H 2 O vs. 13±0.5 mm H 2 O; Po0.0001, Figure 3 ). This finding may indicate not only kidney failure but also the end stage of heart failure, with a markedly increased left ventricular end diastole. Table 2 presents a summary of mortality in post-DOCA-NaClhypertensive Dahl R rats on an 8% NaCl diet after either a sham or a verified aqueductal block. The sham group rats had much higher mortality rates than the truly blocked rats did. After 8 weeks on the 8% NaCl diet, 7 of the 17 sham group rats had died, and 12 sham group rats were dead after 11 weeks, while none of the 16 truly blocked rats had died (both Po0.0001; a 71% reduction). All of the sham group rats had died at the end of 14 weeks on the 8% NaCl diet, while 10 of the 16 truly blocked rats were still alive (Po0.0001; a 65% reduction). The truly blocked rats showed protection from severe mesenteric arterial lesions, tissue water accumulation, ascites and pleural effusions.
In the heart and kidney weight comparisons, cardiac and renal hypertrophy was prominent in the sham group rats ( Table 3 ). The sham group had much heavier mean heart weights than the truly blocked group rats did (2.15±0.07 g vs. 1.47±0.06 g for wet hearts and 0.46±0.02 g vs. 0.30±0.01 g for dry hearts, both Po0.0001; 31% and 34% reductions, respectively). The kidney weights of the sham group averaged 2.83 ± 0.13 g, while the truly blocked rats had Plasma Na concentration in post-DOCA Dahl R rats on an 8% NaCl diet after the aqueductal block. Before receiving the high NaCl diet, the two groups had a similar plasma Na concentration (P ¼ NS), though the sham group had a somewhat higher average. However, after 2 days on the high NaCl diet, the truly blocked group averaged a significantly lower plasma [Na] level compared with the sham control group (Po0.05). The plasma [Na] level of the blocked group returned to the normal physiological range and became similar to that of the sham group after 4 weeks on the same high NaCl diet. Abbreviation: n, number of rats. Abbreviation: n, number of rats.
significantly reduced wet weight (2.05 ± 0.11 g; Po0.0001) and dry weight reductions of 0.56 ± 0.03 vs. 0.43 ± 0.02 (Po0.005; 28% and 22% reductions, respectively). Overt nephrotic syndrome was observed in all of the sham group rats, which had severe ascites, pleural effusions and the edematous body, while these features were absent or considerably delayed in the truly blocked rats.
DISCUSSION
Our results indicate that the aqueduct block partially prevents post-DOCA hypertension and heart and kidney injuries via centralized third ventricular brain signaling in salt-genetic hypertension. Although a high NaCl diet is a well-known causal factor in increased BP, which leads to cardiovascular disease and chronic kidney disease, understanding the relationship between high dietary NaCl intake and increased BP is more complicated than we can recognize. The AV3V is vital for maintaining normal body homeostasis and cardiovascular responses. However, we still do not understand the NaCl mechanisms in raising BP and the role of the brain's NaCl-control center. Our previous studies of Sprague Dawley (SD) and Dahl rats showed markedly attenuated BP and mortality resulting from induced hydrocephalus, 1-4 but we did not find similar results in a large number of stroke-prone spontaneously hypertensive rats. Dahl S and R rat strains derived from the SD rat strain; thus, they may share some genetic components involved in centralized NaCl signaling concepts, which may be linked to NaCl hypertension.
High-salt intake is a major cause of elevated BP, coronary heart disease, increased risk of stroke, left ventricular hypertrophy and renal disease. [17] [18] [19] Studies suggest that hypothalamic regulatory centers are the sites of the activities of mineralocorticoids (MC), which have major effects on salt appetite, thirst and BP. 8, 20, 21 These studies report that DOCA administration in rats resulted in an increased salt appetite, which rapidly reverted to a control level after the end of the DOCA treatment. The changes in DOCA treatment were expressed as the parallel effects of the MC in the hypothalamic regulatory centers for salt appetite, thirst and BP. The activities of the regulatory centers change in response to increased intracellular sodium content with increased membrane permeability of the MC at the cellular level of the regulatory centers. The central action of DOCA was suggested because standard treatment with MC does not induce hypertension, but the same concentration administered into the lateral cerebral ventricle causes hypertension.
In other studies, intraventricular infusion of hypertonic NaCl with DOCA administration induced MC hypertension. The central action of NaCl resulted in an alteration in enhanced vascular responsiveness to norepinephrine, serotonin and angiotensin II (AII), especially in the mesenteric arteries. 22, 23 A pressor effect produced by the intracerebroventricular VP injection resulted in the activation of the sympathetic nervous system, but this effect resulted in a decreased urinary excretion rate. [24] [25] [26] [27] Subsequent studies by other investigators confirmed that intracerebroventricular injection of MC antagonist blocks the hypertension induced by aldosterone 28, 29 and by DOCA. 30 The same dose of the antagonist does not greatly affect BP when given locally through intraperitoneal or subcutaneous injection. The intracerebroventricular infusion of aldosterone also causes a 100-fold more potent hypertensinogenic, which showed neither polydipsia nor polyuria (as seen in saline polydipsia evidenced by polyuria) compared with subcutaneous administration. This result may indicate that the BP regulatory center differs from the thirst regulatory center. However, the center may be identical to central catecholaminergic effector centers, as evidenced by 6-hydroxydopamine or diltiazem blocks that reverse DOCA-NaCl hypertension, while intravenous injections do not. [28] [29] [30] [31] [32] A combination of sympathectomy, using 6-hydroxydopamine and by bilateral adrenalectomy, resulted in a rapid and marked drop in BP in both normotensive and hypertensive animals, but chemical sympathectomy or adrenalectomy alone reduced BP only slightly. 33, 34 This result indicates that DOCA and NaCl may be involved in a synergic hyperactivity of the sympathetic fibers and adrenal medulla.
The rostroventrolateral medulla (RVLM) in the brainstem is a key site for the regulation of vasomotor tone. Sympathoexcitatory neurons project from this region to contact sympathetic preganglionic neurons located in the thoracic-lumbar spinal cord. These neurons are organized for the selective and differential control of autonomic effectors and are particularly involved in cardiovascular regulation. 35 When PVN is stimulated, VP, a spinal neurotransmitter released in the PVN, consistently increases the amplitude of renal sympathetic nerve activity, arterial pressure and the peak-to-peak interval of discharges, while VP antagonists block the hemodynamic response to PVN stimulation, [14] [15] [16] 36 as AII injected intrathecally increases BP and sympathetic activity and an AII antagonist prevents the changes. 37 Bilateral lesions of the PVN and the AV3V reduced NaCl-related hypertension with the many damaged catecholamine-containing neurons in the electrically destroyed regions. 5, 6, 9, 10 We would not expect the same mechanism to be involved in BP reductions with intact cells and nerve fibers in the hydrocephalic 3V regions. Other studies suggest that phenylethanolamine-N-methyltransferase (C1 neurons) from the RVLM are involved in regulating sympathetic outflow and BP, maintaining cardiovascular responses and resting BP in anesthetized rats. 38 The afterdepolarization potential in presympathetic PVN neurons with greater depolarizing input resistance likely contributes to the increased excitability of the PVN-RVLM neurons with AII-salt hypertension. 39 The depletion of 84% of bulbospinal C1 adrenergic neurons did not alter RVLM sympathetic nerve activity and resting BP but this depletion reduced heart rates in anaesthetized rats, while lowering BP with similar heart rates in conscious rats. The loss of C1 neurons reduces sympathoexcitatory and pressor responses, suggesting that C1 cells are critical for the full expression of sympathoexcitatory responses generated by the RVLM. 40, 41 Somatostatin 2A receptors in RVLM presympathetic neurons also appear to maintain resting BP, as evidenced by the ability of somatostatin and receptor-agonists to evoke dramatic hypotension and bradycardia. 42 The activation of PVN neurons in the hypothalamus produced sympathetic nerve activity accompanying a pressor response in decreased renal sympathetic activity, together with an increase in splanchnic, adrenal and cardiac sympathetic activity mediated by gamma-aminobutyric acid, indicate that PVN can be functionally significant in the cardiovascular response induced by blood volume expansion. 43 Intravenous phenylephrine-induced baroreceptor stimulation significantly reduced spinally evoked responses, while glycine injections to the ventral surface of the medulla produced a profound hypotension, during which sympathetic vasoconstrictor activity in splanchnic, renal and skeletal muscle vascular beds was reduced with gamma-aminobutyric acid synapses in the spinal sympathetic circuits. 44 Normal pressure hydrocephalus (NPH) is the most frequent form of chronic hydrocephalus in adults, but the pathogenesis of idiopathic NPH is unknown. 45, 46 Hydrocephalus is caused by an obstruction to the flow of cerebrospinal fluid (CSF), however, a small pressure gradient obstruction to CSF flow is sufficient to overcome the added resistance to flow and thereby balance the absorption of CSF with its production. 47 Enlarged basal cisterns and sylvian fissures and focally dilated sulci support the diagnosis of shunt-responsive idiopathic NPH, a condition caused by a suprasylvian subarachnoid block. 48 In addition, astrogliosis was significantly higher in NPH patients compared with neurologically healthy age-matched controls. 49 Aqueduct CSF stroke volume and peak systolic and diastolic velocity values in the aqueduct of Sylvius were significantly higher in patients with hydrocephalus before shunt surgery and became similar to those of the control group after the shunting surgery. 50 Increased intracranial pressure might stimulate VP release in the CSF and for plasma VP concentrations that are inappropriate to the corresponding plasma osmolality. 51 Despite increased intracranial pressure in hydrocephalic brains, normal BP is maintained in most elderly patients and animals in chronic hydrocephalus. [52] [53] [54] [55] [56] In our current study, the cerebral aqueduct was discretely blocked stereotaxically to produce hydrocephalus. Rats in both groups maintained normal drinking responses and urine excretion. However, the truly blocked rats showed significantly lower amounts of water intake (75.6±6.7 ml per 24 h) and urine excretion (55.3±4.4 ml per 24 h) compared with the sham group rats (96.5 ± 6.9 ml per 24 h for water intake, Po0.005, and 73.7 ± 3.6 ml per 24 h for urine excretion, Po0.0001). The average NaCl intake in the sham rats was also higher than that in the truly blocked group (1.55 g vs. 1.34 g per 24 h; Po0.05). Despite the higher water intake and output of the sham group rats, the average urinary Na excretion was 14% higher in the blocked rats (210.3 mEq l À1 vs. 184.2 mEq l À1 ).
The average BWs in both groups were similar until toward the end stage of hypertension, in which the sham group rats averaged a 6% lower weight than the blocked rats. The transient drop in the plasma Na of the truly blocked group (Figure 2 ) may be influenced by differences in the intake and output of NaCl and water balance or by the central trigger mechanism. Water intake and urinary output interacted significantly 48 h postsurgery among rats on the 8% NaCl diet in both the sham and truly blocked groups, but the interaction was significantly greater with a significant water accumulation in the sham group rats following 2 days on the 8% NaCl diet.
The observations in our and other studies may explain some physiological changes via central and local mechanisms. These acute physiological responses to immediately following the 8% high NaCl diet may be very important features involved in NaCl hypertension. For longer-term effects, we observed that the sham group rats manifested overt nephrotic syndromes, including entire body edema with severe ascites, markedly increased albuminuria (495.71 mg per 24 h in the sham group vs. 181.38 mg per 24 h in the truly blocked group) and massive pleural effusions, and the sham rats died of renal and respiratory failures. These results indicate that kidneys injured by acute DOCA-NaCl hypertension experienced continuing injury that extended to the hearts of the sham blocked rats, while the kidneys of truly blocked rats appeared to be protected from further injury. Truly blocked rats showed protection from severe mesenteric arterial lesions, the leading cause of death in the sham group. It appears that the aqueduct block reduces the post-DOCA-NaCl signal, thereby protecting against post-DOCA hypertension and preventing the vessel injuries of post-DOCA hypertension. We assume that the truly blocked aqueduct reduces hypertensive injuries, perhaps via lowered BP and reduced arterial lesions. However, a recent study suggested that albuminuria was as severe in hypertensives after BP was reduced and kidney vessel pathology was prevented with enalapril treatment. 57 Cardio-renal hypertrophy was prominent in our sham rats. Hypertensive cardiac hypertrophy does not appear to be simply a response to the mechanical stress of increased afterload. Many neural and hormonal stimuli have been proposed in cardiac muscle growth, including adrenergic agonists. Studies have demonstrated that other factors, such as sympathetic activity, might be more important to the degree of cardiac hypertrophy. 58 High NaCl is known to increase sympathetic activity by modifying a release of neurotransmitters and causing changes in b-adrenergic receptors, which can influence cardiac hypertrophy. This finding suggests the possible involvement of the sympathetic nervous system in accelerated cardiac hypertrophy, as observed in our sham-lesioned rats.
Studies indicate that high NaCl affects renal growth differently in salt-sensitive and -insensitive rat strains. Renal hyperplasia was much more prominent, and renal hypertrophy was greatly increased, with longer NaCl feeding in salt-sensitive strains compared with salt-insensitive strains. 59 Increased kidney weights may be caused by renal hyperplasia and cell hypertrophy that existed before the introduction of a high NaCl diet, or they may result from the compensatory hypertrophy of nephrons. Water and cast accumulation in the tissues may also contribute to the heavier kidney weights in our sham group rats. We kept the AV3V region intact but disturbed the intraventricular space by inducing hydrocephalus to test how the salt-volume center perceives the Na signal. We again found attenuated BP and mortality in post-DOCA Dahl R rats, together with acute changes in intake-output and transient plasma Na and long-term effects on venous pressure and cardio-renal protection in hydrocephalic brains. The aqueductal block lowered BP even when the rats were fed 0.3% NaCl chaw as compared with the sham group rats. We also observed mesenteric vascular lesions in many rats in the sham group. However, the phenomena were different from that of Dahl S rats with severe vascular pathological changes without chronic blood loss through the mesenteric arteries. In our Dahl S rat study, many sham group rats had chronic blood loss in the chronic blood clotting process. Sudden cerebral hemorrhaging was not observed in the Dahl R rats as often as in the high NaCl-fed sham-blocked Dahl S rats.
In summary, DOCA-NaCl induces hypertension that causes arterial lesions (especially in cerebral and mesenteric arteries) and organic cellular damage, thus, increasing BP and mortality, while the arterial and local organ lesions are markedly reduced in hydrocephalic DOCA Dahl R rats, similar results seen in our Dahl S rat study. The excessive extracellular fluid volume caused by a high NaCl diet may swell the local tissue at the sites of the slit-like 3V, which could cause the ependymal cells and nerve fibers to touch one another. This contact could trigger neural/humoral signals, resulting in hypertension in susceptible individuals and vascular injuries that lead to increased mortality. Our results indicate that the aqueduct block prevents post-DOCA hypertension and heart and kidney injuries. However, BP was partially reduced in the truly blocked groups, indicating that some other mechanisms may also be involved in saltgenetic hypertension. Unfortunately, we did not measure the potential neurotransmitters that would be involved in this study.
Significant BP reduction can be achieved by a public campaign to reduce dietary salt intake to prevent the salt-induced lesions that lead to cardiovascular disease and chronic kidney disease morbidity and mortality, as no genetic test for salt sensitivity is readily available. A meta-analysis result has suggested that systolic BP was reduced B1 mm Hg with every 1 g per day decrease in salt intake in hypertensive subjects. 60 In our earlier studies, moderate increases in perinatal dietary salt predisposed offspring's salt sensitivity and resulted in adverse effects later in life, when a high-salt was reintroduced. 61 This outcome indicates that epigenetic effects also have a significant role in NaCl-induced hypertension.
FUTURE STUDY DIRECTIONS
NaCl hypertension is involved in various aspects of genetics, which are significantly influenced by environmental factors. Future study designs should include the main factors potentially involved in the centralized signaling concepts in NaCl hypertension, including catecholamines and possible epigenetic and environmental factors.
